Immuron’s shares rise on the back of Travelan® results

Australian biopharmaceutical group, Immuron Ltd (ASX:IMC; NASDQ:IMRN), has provided an extremely promising update on the company’s cooperative research and development agreements with the US Department of Defence, no doubt contributing to its strong share

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.